Olasunkanmi Olaoye, PhD, MS

Clinical/Postdoctoral Fellow
Dana Farber Cancer Institute
Boston, Massachusetts

What are your long-term career objectives? 

“My research leverages molecular biology, chemical biology, and medicinal chemistry methodologies to identify unique cancer dependencies and vulnerabilities. I aim to develop tailored and safe treatment options for rare and underexplored cancers that lack specific medications and are often neglected by conventional drug discovery initiatives. Currently, my primary emphasis is on discovering precision therapies for Ewing sarcoma, a rare pediatric tumor with an unmet clinical need.”

Abstract #3244: EWS-FLI1-driven upregulation of UGT3A2 unlocks drug sensitivity pathway in Ewing sarcoma.

Poster Session: PO.ET09.02